Answers are grounded in this paper and cite their sources.
Biofilm-associated infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA), pose a major clinical challenge due to enhanced antibiotic resistance and metabolic adaptability. Here, we show that Ebselen, a small organoselenium compound, effectively disrupts mature MRSA biofilms and exhibits broad activity against biofilms formed by diverse Gram-positive pathogens. Using clinically relevant in vivo models, including implant-associated osteomyelitis and catheter-associated urinary tract infection, Ebselen significantly reduced bacterial burden and disease progression. Integrated multi-omics and structural analyses identified ArgR, a conserved regulator of arginine metabolism, as the direct molecular target of Ebselen. Mechanistically, Ebselen competitively binds the C-terminal domain of ArgR, suppressing arc operon expression, inhibiting arginine catabolism, and promoting intracellular arginine accumulation, ultimately destabilizing biofilm integrity. Together, these findings establish metabolic disruption of arginine homeostasis as a promising strategy to dismantle multidrug-resistant biofilm-associated infections.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: